Top compounds associated with response to ASXL2


Feature Type Standardized
Nominal ANOVA
mRNA Dasatinib GDSC1000 pan-cancer AAC -0.093 0.07
mRNA PLX4720 CCLE pan-cancer AAC 0.081 0.08
mRNA lenvatinib CTRPv2 pan-cancer AAC 0.065 0.08
mRNA PD-0325901 CCLE pan-cancer AAC 0.078 0.08
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC 0.067 0.08
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.062 0.08
mRNA Zebularine CTRPv2 pan-cancer AAC 0.06 0.08
mRNA B02 CTRPv2 pan-cancer AAC 0.064 0.08
mRNA BMS-754807 GDSC1000 pan-cancer AAC 0.06 0.08
mRNA SB52334 GDSC1000 pan-cancer AAC 0.059 0.08
Download CSV